These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1837152)
41. Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor. Sircar R; Soliman KF Pharmacol Biochem Behav; 2003 Mar; 74(4):943-52. PubMed ID: 12667909 [TBL] [Abstract][Full Text] [Related]
42. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Irifune M; Shimizu T; Nomoto M; Fukuda T Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342 [TBL] [Abstract][Full Text] [Related]
43. Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys. Koek W; Woods JH; Jacobson AE; Rice KC; Lessor RA J Pharmacol Exp Ther; 1986 May; 237(2):386-92. PubMed ID: 3009781 [TBL] [Abstract][Full Text] [Related]
44. Behavioral effects of phencyclidine and some of its metabolites in developing cats. Levine MS; Howard-Butcher S Pharmacol Biochem Behav; 1986 Aug; 25(2):359-63. PubMed ID: 3763662 [TBL] [Abstract][Full Text] [Related]
45. Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats. Fessler RG; Sturgeon RD; London SF; Meltzer HY Psychopharmacology (Berl); 1982; 78(4):373-6. PubMed ID: 6818601 [TBL] [Abstract][Full Text] [Related]
46. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors. Yamaguchi K; Nabeshima T; Kameyama T J Pharmacobiodyn; 1986 May; 9(5):479-89. PubMed ID: 2945001 [TBL] [Abstract][Full Text] [Related]
47. Effects of naloxone, metenkephalin, and morphine on phencyclidine-induced behavior in the rat. Castellani S; Giannini AJ; Adams PM Psychopharmacology (Berl); 1982; 78(1):76-80. PubMed ID: 6815700 [TBL] [Abstract][Full Text] [Related]
48. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Bristow LJ; Hutson PH; Thorn L; Tricklebank MD Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625 [TBL] [Abstract][Full Text] [Related]
49. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. Snell LD; Johnson KM J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174 [TBL] [Abstract][Full Text] [Related]
50. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat. Klamer D; Zhang J; Engel JA; Svensson L Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002 [TBL] [Abstract][Full Text] [Related]
51. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. Tanii Y; Nishikawa T; Hashimoto A; Takahashi K J Pharmacol Exp Ther; 1994 Jun; 269(3):1040-8. PubMed ID: 8014848 [TBL] [Abstract][Full Text] [Related]
52. Discriminant effects of behaviorally active and inactive analogs of phencyclidine on membrane electrical excitability. Aguayo LG; Weinstein H; Maayani S; Glick SD; Warnick JE; Albuquerque EX J Pharmacol Exp Ther; 1984 Jan; 228(1):80-7. PubMed ID: 6319672 [TBL] [Abstract][Full Text] [Related]
53. Effects of chronic administration of phencyclidine on stereotyped and ataxic behaviors in the rat. Smith RC; Biggs C; Vroulis G; Brinkman S Life Sci; 1981 Mar; 28(10):1163-74. PubMed ID: 7194953 [No Abstract] [Full Text] [Related]
54. Discriminable effects of phencyclidine analogs evaluated by multiple drug (PCP versus OTHER) discrimination training. Overton DA; Shen CF; Ke GY; Gazdick LP Psychopharmacology (Berl); 1989; 97(4):514-20. PubMed ID: 2498947 [TBL] [Abstract][Full Text] [Related]
55. Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (PCP) receptor ligand, with the N-methyl-D-aspartate-coupled and -uncoupled PCP recognition sites. Rao TS; Contreras PC; Cler JA; Mick SJ; Dilworth VM; Iyengar S; Monahan JB; Wood PL J Neurochem; 1991 Mar; 56(3):890-7. PubMed ID: 1847186 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats. Nicholson KL; Balster RL Psychopharmacology (Berl); 2003 Nov; 170(2):215-24. PubMed ID: 12851738 [TBL] [Abstract][Full Text] [Related]
57. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. Witkin JM; Steele TD; Sharpe LG J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180 [TBL] [Abstract][Full Text] [Related]
58. Solubilization of rat brain phencyclidine receptors in an active binding form that is sensitive to N-methyl-D-aspartate receptor ligands. Ambar I; Kloog Y; Sokolovsky M J Neurochem; 1988 Jul; 51(1):133-40. PubMed ID: 2898002 [TBL] [Abstract][Full Text] [Related]